Director: The special effects are too expensive, so I had to make real shots

Chapter 98 A High-Tech Company Delayed by Movies
The host Wang Bingbing was stunned on the spot.

The young man I interviewed, why is he so radiant?
His charm at this moment, for almost everyone, is instantly full!
But Wang Bingbing, who has a very high professionalism, quickly came back to his senses, fixed his eyes on Xu Nuo and asked in disbelief: "Director Xu Xu, are you talking about the rumored new drug for treating chronic myelogenous leukemia? Developed by your company?"

"Yes."

Xu Nuo nodded affirmatively.

This is Xu Nuo's big move in today's national TV live interview, which is to officially announce the new generation of tyrosine kinase inhibitor [Ponatinib] developed by his company.

Since the Department of Medicine has already passed the approval, [Ponatinib] has only been on the market for a few days. Originally, Xu Nuo was still thinking about how to announce this news.

Unexpectedly, at this time, the national TV station contacted me and invited me to do a live interview about the movie "I am not the God of medicine".

Isn't this just an opportunity?

Before this, many netizens who were out of rhythm called Xu Nuo and the producer of "I'm Not the God of Medicine" to ask Xu Nuo to share half of the box office money of "I'm Not the God of Medicine" with those who develop new drugs What about the company.

When Xu Nuo saw this rhythmic speech, he almost didn't laugh out loud.

Fortunately, Xu Nuo's work is professional, and he can usually hold back his laughter.

And when everyone saw that Xu Nuo said that the new drug was developed by their company and that it was about to be approved for marketing, they exploded instantly!
"Fuck! Director Xu! You are a fucking god!"

"The light of God seems to be shining on Director Xu!"

"Director Xu, you are my kun!"

"Oh my god, it was actually developed by Director Xu's company?"

"How is this new drug compared to imatinib from the European Norin Pharmaceutical Group?"

"Really or not, what the hell?"

"This fucking shocked me for 100 years!"

"Director Xu, how can you be so awesome, you made such an excellent movie as "I'm Not the God of Medicine", and you even developed a new drug."

"As a chronic myelogenous leukemia patient, Director Xu, I thank you from the bottom of my heart!"

"I apologize for questioning Director Xu's remarks just now, I'm sorry Director Xu!"

"Brothers, this man is the incarnation of God, right?"

"When Director Xu said that I hope there will be no disease in the world, I would rather put medicine on the shelf to make dust, I knew that this man is not simple."

"I just want to know, is our new domestic drug reliable? How much does it cost?"

The emotions of the netizens are boiling. At this moment, it seems that the man in the picture has a divine radiance. How can he be so awesome?

You make a good movie about CML and forget it.

Your company has developed all the new domestic drugs to treat this disease!
No wonder Director Xu, you had the confidence to anger European Nori Pharmaceutical Group at the beginning!
As the news of the explosion spread from the live talk show on State TV, it spread rapidly. Only a few minutes later, on Weibo, Xu Nuo and the new drug for chronic myelogenous leukemia went straight to the top of the list.

More and more people know that the domestically produced new drug for chronic myelogenous leukemia that is currently being developed is actually developed by Director Xu and his company. Then there is extreme surprise and excitement!
The most important thing is that Director Xu said that this new drug named [Ponatinib] has been developed and completed clinical trials, and it will be launched soon after being approved by the Department of Medicine.

Good guy, Director Xu, you are really good at hiding!
It turns out that Director Xu has been silently contributing to the group of patients with chronic myelogenous leukemia. In a big way, Director Xu has taken a milestone step for Huaguo's medical cause.

Because the significance of this matter is far more than just the birth of a new drug.

This means that our own pharmaceutical companies can break through the drug coercion of foreign pharmaceutical capital, so that domestic CML patients can truly live with dignity!

Today is a patient with chronic myelogenous leukemia, this is a beginning, and perhaps patients with other diseases will have such hope in the future!

Even the Department of Medicine knows the profound implications.

So when Xu Nuo officially announced the news on the live interview of Guoshi TV, the official account of the Medical Administration immediately posted a Weibo.

【Pharmaceutical Administration】v: Starting today, chronic myelogenous leukemia patients will no longer be desperate, and sky-high priced drugs will disappear in the long river of history. After the joint efforts of our Medical Administration and real technology, we can be sure that we Every chronic myelogenous leukemia patient in Huaguo can afford life-saving medicine. I would like to thank Xu Nuo and his biomedical research and development team for their great contributions to the medical cause of our country. Salute!

This Weibo post from the Department of Medicine is a far cry from Xu Nuo's.

This directly proves that the new drug [Ponatinib] that Xu Nuo said in the live broadcast of the national TV interview has been approved by the Department of Medicine, and the news that it will be launched soon is true!

At this moment, all those who questioned Xu Nuo disappeared.

"Has the Department of Medicine confirmed this? My God, it is indeed true!"

"Can you tell me how much this new drug sells for?"

"The Department of Medicine's words are simply too confident!"

"I guess it's two or three thousand heavens at most, right?"

"I think it should be under [-], because the Medical Administration said that every chronic myelogenous leukemia patient in China can afford life-saving medicine."

"Is there a possibility that it is less than 1000 yuan?"

"Less than one thousand? Director Xu's company must pay back its capital. After all, this kind of thing is not charity."

"Looking forward to the announcement of the price, but I think since the Department of Medicine has said so, the price will definitely not be too high."

"Think about the imatinib of Europe's Nori Pharmaceutical Group, which sells for about [-] in the United States and Europe. The new domestic drug of Director Xu is probably also at this price?"

Now netizens are very concerned about the price of this new drug [Ponatinib]?
After all, the imatinib of the European Nori Pharmaceutical Group has been sold at 27000 yuan a box in China. The new drug developed by Xu Dao and his company will not be as cheap as 2700 yuan a box, right?

Could it be ten times cheaper?

For netizens, if it is really ten times cheaper, it will definitely be a conscientious enterprise in everyone's mind.

At this time, it was on the live interview program of the national television station.

Wang Bingbing played her best on the spot, and continued to chat about the topic of Xu Nuo's company developing a new drug for chronic myelogenous leukemia.

Although this topic was not planned to be in the topic book of the previous program, Wang Bingbing knows that this topic is definitely the most concerned by netizens now, and since Director Xu has mentioned it, it means that this topic can be discussed.

"It's unbelievable. Director Xu, what you said just now is that the new drug has passed the approval of the Department of Medicine, and will it be on the market soon?"

Wang Bingbing asked curiously.

"Yes."

Xu Nuo replied calmly, and after a pause, he added: "I believe that in a few days, patients with chronic myelogenous leukemia will be able to see this affordable new drug from our company in major pharmacies."

"This is really great news. Thank you so much, thank you, your company, and the R&D team for their contribution!"

Wang Bingbing said sincerely.

At this moment, Wang Bingbing has the highest respect for Xu Nuo, his company, and the pharmaceutical research and development team.

So did countless netizens who learned the news!
"you are welcome."

Xu Nuo smiled, and continued: "Here, I just want to tell those foreign medical capitals who regard our Huaguo as a market for gold, that you will never understand what a doctor's benevolence is!"

Xu Nuo's words can be said to be euphemistic and full of satire on foreign medical capital!

"That's very good. The benevolence of doctors is a traditional good quality of our country. Whether it is in the past or in the future, our Huaguo will always have companies, teams and individuals like Dao Xu and your company who have the benevolence of doctors."

Wang Bingbing immediately sublimated Xu Nuo's words.

Netizens watching the live broadcast immediately boosted their confidence a lot when they saw this.

Director Xu has a structure, a doctor's benevolence, and dares to "speak out" to foreign medical capital, which is really tough!

Then the problem is coming.

Director Xu, how much does your company's new drug sell for?

Wang Bingbing also wanted to know the answer, so she asked cautiously: "Then Director Xu, would you be convenient to disclose the price of this new drug that your company is about to launch?"

Before Xu Nuo left the Department of Medicine, he asked Hua Shizhen if he could disclose the price of [Ponatinib] after it was launched when he participated in the live interview program of State TV.

Hua Shizhen's answer is yes.

Because this drug will be on the market soon, the Department of Medicine will wait for an opportunity to announce the official price of [Ponatinib] in the next two days.

If this is the case, why not let Xu Nuo take advantage of this live interview on National TV to announce the price of the new drug to the public.

"of course can."

Xu Nuo replied very heartily: "Our new drug has carried out in-depth cooperation with the Department of Medicine, and has been approved to officially join the medical insurance. The Department of Medicine supervises the sale of hospitals and pharmacies. The comprehensive price fluctuates around 278 yuan. The specific price will vary. Depending on the economic level of each province and region, the maximum selling price will not exceed 500 yuan."

When Xu Nuo said this, even Wang Bingbing's eyes widened in disbelief!

At the price of two or three hundred yuan, you can buy the life-saving medicine that once cost two to three hundred thousand yuan?
The sky-high priced medicine instantly became a cheap medicine!
"More than 200?"

"Why is it so cheap?"

"The price is 666!"

"My God, Director Xu, can you still make money by selling it like this?"

"Woooooo, I don't want to see your company selling medicine at a loss."

"It is estimated that there should still be some profits, otherwise it would be impossible to sell so low."

"I feel that the profit should be very meager. How many boxes do I have to sell to recover the research and development costs?"

"Selling medicine at a loss?"

"Director Xu, I was diagnosed with chronic myelogenous leukemia last year. After a year, my family's finances could no longer support me and I continued to take medicine. I wanted to commit suicide, but Liu Yong's appearance saved me once, but now you It brought me the hope of living, and my life will be yours from now on!"

Everyone can't believe that such a life-saving medicine that was once sky-high can now be bought for only a few hundred dollars?
It is understandable to say that the generic drugs of A Sanguo cost a few hundred yuan and 1000 yuan, because they are produced by imitation, only the production cost, no research and development cost, so they are sold so cheaply.

But Director Xu, doesn't your company consider the cost of research and development?
Regarding the doubts of the audience, Wang Bingbing seemed to have a tacit understanding, and then asked: "Director Xu, is this price really profitable?"

Hearing this, Xu Nuo said with a smile: "I wonder if you, Bingbing, have forgotten to consider the medical insurance of the Department of Medicine. In fact, the price of our drugs is not two or three hundred yuan, because as you said, our company also We need to consider cost recovery and some meager profits, so the initial price is 2000 yuan per box. In fact, this price is not a small expense for many ordinary families, but after our country’s medical insurance subsidy, the final sale The price was set within the range of [-] yuan, we are very honored to have a strong country as the strong backing of each of us!"

It is certainly impossible for Xu Nuo to take all the credit for himself.

The drug was indeed developed by its own company, but it took a lot of effort and money from the Department of Medicine to set the price so low.

And Xu Nuo's words are equivalent to dividing the credit into two parts, one part is his own company, and the other part is the Department of Medicine and the powerful motherland behind it!
in fact.

The price after the medical insurance subsidy of the Department of Medicine was also a suggestion to the Department of Medicine after careful calculation by Xu Nuo and Guan Ju.

Because when the company's new drug [Ponatinib] is on the market, the European Nuori Pharmaceutical Group will inevitably take action. After all, how can they be willing to lose such a huge chronic myelogenous leukemia drug market in Huaguo?

So just like the machine tool price war that hasn’t come yet, the European Nuo Rui Pharmaceutical Group will inevitably cut prices to fight a price war with Xu Nuo’s company. It is to use low prices to delay your company for a short period of time or even a long period of time. R & D costs, until the end was dragged to death.

This is also a problem that domestic innovation and R&D in many fields often encounter after keeping up with the pace of world science and technology.

Just like a lithography machine and a chip!
Because overseas lithography machines, chips and other industrial chain technology products are several levels ahead of the domestic ones, whenever the country spends a huge amount of money to break through the technology and draws the distance from overseas, it will face such a fatal crisis. question.

But Xu Nuo is not afraid of price wars with foreign pharmaceutical capital, because he has the support of the Department of Medicine behind him.

When working, Xu Nuo can completely let go of his hands and feet.

Secondly, his new drug [Ponatinib] is a formulation technology obtained from the system, and the cost is basically negligible, after all, it is exchanged with entertainment points.

As for entertainment, I can earn money just by making movies.

This time, Xu Nuo asked Guan Ju to make a careful calculation, calculating how much the European Nuo Rui Pharmaceutical Group's drug imatinib can reduce to the lowest price to suppress Xu Nuo's new drug.

After Guan Ju obtained the data through various methods and channels, after some calculations with the support of large-scale supercomputers, it was calculated comprehensively from various aspects such as R&D costs, raw materials, production, transportation, and tariffs. The group's 27000 yuan a box of new medicines can be sold domestically at a price of around 1000 yuan at most.

Otherwise it is a loss!

Another way is to negotiate medical insurance with the Department of Medicine after the price is reduced to this price.

This time, Xu Nuo and the Department of Medicine jointly controlled the price of the new drug [Ponatinib] within 500 yuan.

This means that the domestic market of imatinib of European Nori Pharmaceutical Group has been completely blocked!
What Xu Nuo said just now undoubtedly boosted the confidence of every Chinese.

Yes, a powerful country and a responsible company joined hands and finally gave the extremely arrogant European Norry Pharmaceutical Group a heavy blow!
"Director Xu said it so well, you are simply my idol!"

"If there is a guarantee from the Department of Medicine, does this mean that the imatinib of the European Nori Pharmaceutical Group will have to get out of China?"

"This time I finally have the confidence to say boycott the sky-high price of drugs from the European Nori Pharmaceutical Group."

"What if Nuori Pharmaceuticals cuts prices sharply?"

"Hahahaha, Nuori Pharmaceutical Group has the ability to reduce it to two or three hundred yuan. This is a great thing."

"It is estimated that the European Nuori Pharmaceutical Group will not be able to reduce the price to such a low price. It has nothing to earn. Don't forget that this new drug from Dao Xu's company has a price subsidy from the Department of Medicine."

"Oh, now the European Nori Pharmaceutical Group is going to send a package."

What netizens don't know is that the European Norry Pharmaceutical Group is already an ant on the hot pot at this time, and it is extremely anxious!
Europe, Norrin Pharmaceutical Group Headquarters Building.

When several senior executives of the company learned the news that Huaguo had developed a new drug for the treatment of chronic myelogenous leukemia, they were all about to be blown away!
Huaguo is a huge chronic myelogenous leukemia drug market.

Every year, the European Nori Pharmaceutical Group can make a lot of profits there by virtue of the patented drug "Imatinib".

but!

This all changed overnight!

Before this, they had no news at all that the local pharmaceutical companies in Huaguo had developed a new drug for the treatment of chronic myelogenous leukemia. Even if they heard that someone was developing it, it was just a joke.

Because the Europeans believe that it is very difficult to develop this new drug in the local pharmaceutical research and development environment of Huaguo, and the investment cost is extremely high, and the payback period is very long.

And we must also take into account the price competition with the European Norry Pharmaceutical Group after the new drug is developed!
however!
This time, they were completely stunned. Huaguo's real technology new drug [Ponatinib] was only sold at a price of less than 500 yuan in Huaguo.

Noland, the CEO of Nuori Pharmaceutical Group, has been calculated by others just now. If the price of the imatinib drug of his group is reduced to less than 500 yuan, then there will be no profit at all, and even a loss, because it has to be repaid. Production costs, tariffs and other issues have to be considered.

"Fake!"

Noland was so angry that he threw his glass, and immediately yelled at the people around him: "Has the new calculation result come out? How much do we have to drop to keep the price? We can't lose the Huaguo market of imatinib, understand ?"

"Noland, calm down."

Summerfield came forward to reassure the CEO: "We can restart the medical insurance negotiations with the Huaguo Pharmaceutical Administration, so that after our imatinib price is reduced to more than 1000 yuan, if it enters Huaguo again The medical insurance of the Department of Medicine, then our medicines are also competitive!"

As a director and a think tank of the European Nori Pharmaceutical Group, he is much calmer now.

Despite the huge threats to the future of imatinib, he sees room for maneuver.

"So how much profit do we have left? That's almost no profit."

Noland took a deep breath, and couldn't help cursing: "Fuck, doesn't that real technology cost nothing to develop new drugs? You dare to set the price so low, you really deserve to die!"

"At the beginning, I suggested that we need to iteratively develop new drugs in the field of tyrosine kinase inhibitors. You just didn't listen, and you are conceited. Do you know the price of conceit!"

Summerfield was also annoyed.

Due to the medical technology for the treatment of chronic myelogenous leukemia in this parallel world for a long time, only the European Nuori Pharmaceutical Group has the drug technology patent of imatinib.

Therefore, the European Nori Pharmaceutical Group made a fatal mistake, that is, as Summerfield said, it did not continue to invest in research and development funds to iteratively develop new drugs.

This is like a person living too comfortably and earning a lot of money while lying down, then this person will easily lose his motivation to be motivated.

This is the case with the European Nori Pharmaceutical Group. They believe that they have mastered the lifeblood of chronic myelogenous leukemia patients around the world, making a lot of money, and they have not had any challengers for so many years.

So I slack off the research and development of new drugs!
But what they never thought of was.

At this time, Huaguo turned out to be a company that dared to challenge them, and the most important thing was that the challenge was successful.

"It's useless to say more now, Summerfield. We need to think about how to keep the market in Huaguo. Even if we earn less, multiplied by hundreds of thousands, that's a huge profit."

Now Norland is more worried about the Huaguo market that will be lost at any time.

Although European Nori Pharmaceutical Group does not only have the drug patent of imatinib, after all, as a large international pharmaceutical company, it must have a lot of drug patents.

But there are only a handful of drugs like imatinib that can bring high profits. Who made this a life-saving drug!
If the patient does not eat it, there is only a dead end.

Often the more the drug is related to the life and death of the patient, the more profitable it is!

Therefore, once the European Nori Pharmaceutical Group loses the imatinib market in China, it will lose such a revenue growth point, and it may not even take long, which may affect the global sales of this drug.

"I've sent someone to contact Huaguo's Medical Administration, wait for news."

Summerfield has no other better solution at this time, and can only wait for the news from the Huaguo Medical Administration, hoping that imatinib can be included in the medical insurance smoothly.

"When we were negotiating with the Huaguo Medical Administration for medical insurance, we should think carefully about it. I didn't expect you to refuse it and drag it until now. Stupid, really stupid!"

Summerfield was really pissed off.

I have repeatedly given opinions on the board of directors that can prevent the current situation, such as investing in the development of iterative new drugs for the treatment of chronic myelogenous leukemia.

And when negotiating with the Huaguo Medical Administration to enter the medical insurance, I agreed to find a suitable profit point.

In the end, all my suggestions were rejected by the group of worms on the board of directors!
The huge profits from long-term high-priced medicines have already dazzled their minds. Now that the backlash has finally arrived, do you know it's urgent now?

"Summerfield, I have to admit how reasonable your original opinion was."

Noland sighed and said helplessly, "Let's go, the board meeting will be held soon."

Just at this time.

Summerfield received a call: "What? The Huaguo Pharmaceutical Administration refused to negotiate with us on imatinib?"

"Fake!"

At this moment, the blood pressures of Noland and Summerfield went up immediately.

That's right, when the European Uno Pharmaceutical Group realized the crisis, it immediately approached the Department of Medicine to continue the medical insurance negotiations for imatinib.

But sorry.

In the past, you were invited to negotiate medical insurance and you pretended to be cold, but now it’s all right, I have a new love!
Only three days later.

The first batch of [Ponatinib] produced by Yuzhou Pharmaceutical Factory was sent to hospitals all over the country.

For hundreds of thousands of patients with chronic myelogenous leukemia in China, this day is like a day of rebirth.

They can finally buy affordable life-saving medicine.

However, imatinib of the European Nori Pharmaceutical Group has become "history". Domestic patients with chronic myelogenous leukemia no longer need this once sky-high priced drug. Won't look at it again.

Because the pain it once brought to domestic patients is difficult to heal.

How many patients with chronic myelogenous leukemia chose to end their lives because they couldn't afford it, or lived in endless pain.

It could have been a more affordable life-saving drug.

But the foreign medical capital behind it turned it into a sickle full of blood!

now.

Chinese people have their own domestically produced new drugs, which are affordable and affordable to every patient with chronic myelogenous leukemia.

They have the hope of surviving!

This time, European Nori Pharmaceutical Group quietly let its own imatinib withdraw from the Huaguo market, and in order to stabilize the market in other parts of the world, it had to choose to lower the price of imatinib to a certain extent. .

After all, the market in Huaguo has been lost, and the market in other countries and regions can no longer be lost, otherwise this medicine of his own will be completely reduced to history.

Although the price of imatinib of the European Nori Pharmaceutical Group is around 1 yuan in the United States and Europe, considering that Xynomic's new drug will definitely enter the international market.

Therefore, the European Nuori Pharmaceutical Group had to quickly choose to cut prices to protect its own market share.

Even if Xu Nuo's new drug is to enter the international market, it will not be priced as low as it is in China, because the European Nuo Rui Pharmaceutical Group also understands that Xu Nuo's new drug can be sold so cheaply in China. It is because there is a price subsidy from the Department of Medicine behind the scenes.

But overseas is not so simple.

What European Nori Pharmaceuticals Group doesn't know is that Xynuo's [Ponatinib] is much stronger than your imatinib in terms of efficacy.

And in terms of side effects, it is also the lowest.

After waiting for a long time, even if two medicines are sold at the same price, the gringo will know which one to buy. After all, the gringo is not stupid, he is very smart!
In the past few days when [Ponatinib] was officially listed, the praises of Xu Nuo and his company from the entire domestic network can be said to be overwhelming.

Xu Nuo's "I'm Not the God of Medicine" created a box office miracle because of the peak popularity of "Ponatinib".

That is, the single-day box office on weekdays actually exceeded the single-day box office of the first weekend of its release.

Because the box office of "I'm Not the God of Medicine" was more than [-] million on both Saturday and Sunday of the first weekend of its release, and on Wednesday, the single-day box office of "I'm Not the God of Medicine" unexpectedly exceeded [-] million yuan. [-] million.

A reversal has been achieved!

Many viewers went into the cinema to support Xu Nuo's "I'm Not the God of Medicine" after knowing that the new domestic CML drug was developed by Xu Dao's company.

There are even many viewers who have already seen it and go directly to the second brush and third brush!
For a while, even on weekdays, there was a movie-watching frenzy, and the box office soared to exceed 20 billion at an extremely fast speed.

And Xu Nuo reckoned that in the second weekend at most, the box office of "I'm Not the God of Medicine" will exceed 30 billion. After all, even the box office results on weekdays can be so strong, it's like riding a rocket. There will definitely be more people walking into the cinema to watch their own "I'm Not the God of Medicine".

This is similar to what Xu Nuo expected at the beginning.

As long as the company's development of [Ponatinib] breaks out during the release of "I'm Not the God of Medicine", then the bonus to the movie's box office performance will definitely be rocket-like.

And as the popularity of the movie "I'm Not the God of Medicine" continues to soar, and people discuss more and more topics about Xu Nuo, the director, and his company, gradually began to form a popular meme on the Internet.

That is, Xu Nuo's company is simply a high-tech company delayed by the movie.

From last year's AI technology, to this year's Transformers car, to today's biomedical technology, this company is dancing wildly at the forefront of technology.

What people are most familiar with about Xu Nuo Company is actually a movie produced by this company.

From "Terminator" to "Transformers" to "I'm Not the God of Medicine", every movie is very popular. film works.

And as some bigwigs concerned about the field of machinery manufacturing continue to reveal some news, the news that Xu Nuo's company is leading the rise of domestic high-end machine tools and high-end machinery manufacturing has also spread like wildfire.

Because high-end machine tools and high-end manufacturing industries generally don't pay much attention to ordinary people.

Therefore, Xu Nuo's company took over and revitalized the Shenji Factory, and began to deploy domestic high-end machine tools and machinery manufacturing, which has always been somewhat unknown.

This time.

When people gradually realized that the company of the good guy Xu Daoyou is a technology company that was delayed by the movie, people discovered that it was not just what everyone saw.

Even domestically produced high-end machine tools, the mother of industry, and high-end machinery manufacturing, a bright pearl field, are rapidly rising because of Xu Dao's cutting-edge technology!

[Hot search number two] #真人科技和国家技术机#
Topic discussion degree: 1.0 million

"I'm a good boy, Director Xu, is there anything your company can't do?"

"Artificial intelligence, high-end machine tools, biomedicine, good guy Director Xu, your company covers a wide range of things. I thought it was an entertainment company that makes movies."

"Sure enough, it is a technology company that has been delayed by entertainment movies."

"Hahahaha Director Xu is silently doing something important!"

"This is too strong. Whether it's artificial intelligence, high-end machine tools, or biomedicine, this course is a cutting-edge technology field that costs a lot of money!"

"I suspect that Director Xu's company may also be engaged in military industry."

"I also have this feeling. Otherwise, why did the military give so much support for the last filming of "Transformers"? Is it because Director Xu is handsome?"

"Don't just talk nonsense here, Director Xu's crappy company is still engaged in military industry, it's a toy factory if it dies."

"That's right, it's just a toy factory that sells toys all over the world."

"It's fake, it's all fake, Xu Nuo is a bad movie maker, how can he know so many high-tech!"

Originally, netizens on the Internet were discussing Xu Nuo's company, and at the beginning they all said it was awesome, so many high-tech fields can be so good, but after a while, the rhythm of the discussion changed.

Everyone said it.

How can there be any cutting-edge technology, such as military industry, they are just toys!

Do you think that all the products sold by Real Technology are Transformers toys?

Someone is setting the rhythm.

But Xu Nuo didn't say who it was→_→

On Saturday, the second weekend after the release of "I'm Not the God of Medicine", the box office successfully broke through 30 billion, and it will be a matter of time before this rhythm breaks 40 billion. This speed is so fast that other domestic Directors are crazy.

Director Xu, you released two blockbuster movies within a year, what kind of fairy director are you!

The most important thing is, you are so curvaceous, how can we directors live!
A director who is at the top of his game can usually produce a film that can achieve good box office results in two years. With the continuous improvement of special effects production efficiency of real special effects studios, there may be one film a year in the future. director.

But a director like Xu Nuo who releases two films within one year, both of which are top blockbusters, is absolutely unprecedented!
He directly pulled the degree of introversion of domestic films to a horror level.

Perhaps Director Xu will be the only one in terms of reputation and status among domestic directors in the future, followed by first-rate directors like Li Mou and Wang Shifeng.

[Congratulations to your movie "I'm Not the God of Medicine" successfully completing the box office task, and your movie project "I'm Not the God of Medicine" has successfully concluded! 】

[You have won the movie project "I'm Not the God of Medicine" settlement rewards: [Anti-cancer specific drug formula technology] +1, [Chinese medicine knowledge and Chinese medicine formula (full)], entertainment points +5! 】

When the box office of "I'm Not the God of Medicine" successfully exceeded 30 billion at the weekend, Xu Nuo officially completed his third film project.

And get rich rewards!
Every time Xu Nuo finishes shooting a movie and completes all the movie tasks, he can get a generous reward.

Last time after filming "Transformers", he obtained top-notch technology and knowledge in the city's machinery. This time it was undoubtedly related to medicine, but Xu Nuo was surprised.

In addition to an anti-cancer specific medicine formula technology, there is actually a reward about traditional Chinese medicine.

One is a reward for the modern medical formula technology of western medicine, and the other is a reward for a complete book of traditional Chinese medicine. It seems that the system also believes that human medicine in this world is composed of both, and both are indispensable.

Although Xu Nuo is not a medical expert, let alone an old Chinese doctor, he knows how rich these two rewards are.

Not to mention the specific anti-cancer drugs, just the [Comprehensive Treatise on Traditional Chinese Medicine and Formulas of Traditional Chinese Medicine (Complete)] is enough to revive the complete and complete system of Chinese medicine in Huaguo.

Huaguo's Chinese medicine is actually quite powerful, but it has been passed down from generation to generation, and today there are fewer and fewer old Chinese medicine practitioners, and young Chinese medicine practitioners are at half-baked levels. If this continues, Huaguo's Chinese medicine may one day become history A mark in the long river.

And after Xu Nuo has this, if he combines his own AI technology, he may be able to turn the personal health robot Dabai he wants to build into an old Chinese medicine doctor who has mastered all the knowledge of Chinese medicine.

In this way, Dabai will be able to provide patients with two treatment options of Western medicine and Chinese medicine.

Good guy.

Xu Nuo suddenly felt that the burden of revitalizing Chinese medicine seemed to fall on him all of a sudden.

Of course, this is just Xu Nuo's rough idea, and he will spend more time thinking about how to make good use of the rewards he has obtained.

Just as Xu Nuo was thinking about it, the assistant Wen Ruohan happily returned to Xu Nuo's smart villa, holding in her hand a box of the new chronic myelogenous leukemia drug [Ponatinib] that she just bought at the hospital today. 】.

"Boss, I bought medicine, 250 a box!"

Wen Ruohan's happiness was all written on his face.

Mom no longer has to worry that I can't afford medicine!
"Look how happy you are."

Xu Nuo temporarily put away his system panel, picked up a red box from the side, and put it on the table: "To maintain good health, you can't just rely on taking medicine. Although ponatinib is very effective in treating chronic myelogenous leukemia , but while you are taking medicine, you also need to monitor your heart rate, blood pressure and other side effects.”

"Yeah, boss, I know, boss, what is this?"

Wen Ruohan nodded quickly.

"A medical assistant, with it, we can monitor our health every day." Xu Nuo slapped the red box twice.

"Medical assistant?"

Wen Ruohan's face was full of doubts, and he poked his head over and looked at it for a while. Isn't this just an ordinary red box?
Could it be some kind of medical device?
It doesn't look like it.

"Boss, how do you use this thing?" Wen Ruohan raised his head and asked curiously.

"Come on, give me a punch!"

(End of this chapter)